We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cytocom Inc | NASDAQ:CBLI | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.17 | 3.18 | 3.41 | 0 | 01:00:00 |
FORM 8-K
|
Delaware
|
001-32954
|
20-0077155
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification Number)
|
4333 Corbett Drive, Suite 1082
Fort Collins, CO 80525
|
||
(Address of Principal Executive Offices and zip code)
|
||
(888) 613-8802
|
||
(Registrant's Telephone Number, Including Area Code)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common stock, par value $0.005
|
STAB
|
NASDAQ Capital Market
|
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
|
In September 2022, the Company executed multiple subscription agreements pursuant to which the Company sold 4.75 million shares of its common stock for approximately $0.36 million and issued warrants to purchase approximately 9.5 million shares of common stock. The purchase price for one share of common stock and two warrants was $0.075. The warrants are exercisable immediately, have an exercise price of $0.15 per share, and will expire two years from the initial exercise date. The proceeds of the offering will be used for general corporate purposes. |
Exhibit No.
|
Description
|
|
10.1
|
||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
Statera Biopharma, Inc.
|
|||
Date: October 17, 2022
|
By:
|
/s/ Michael K. Handley
|
|
Name: Michael K. Handley | |||
Title: Chief Executive Officer |
1 Year Cytocom Chart |
1 Month Cytocom Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions